AAAAAA
Results: 26-40/40
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., (67)Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma, CLIN CANC R, 5(10), 1999, pp. 3330S-3336S
Authors:
Mirick, GR
O'Donnell, RT
DeNardo, SJ
Shen, S
Meares, CF
DeNardo, GL
Citation: Gr. Mirick et al., Transfer of copper from a chelated Cu-67-antibody conjugate to ceruloplasmin in lymphoma patients, NUCL MED BI, 26(7), 1999, pp. 841-845
Authors:
DeNardo, SJ
Kroger, LA
DeNardo, GL
Citation: Sj. Denardo et al., A new era for radiolabeled antibodies in cancer?, CURR OP IM, 11(5), 1999, pp. 563-569
Authors:
DeNardo, GL
O'Donnell, RT
Rose, LM
Mirick, GR
Kroger, LA
DeNardo, SJ
Citation: Gl. Denardo et al., Milestones in the development of Lym-1 therapy, HYBRIDOMA, 18(1), 1999, pp. 1-11
Authors:
DeNardo, SJ
DeNardo, GL
Brush, J
Carter, P
Citation: Sj. Denardo et al., Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT, HYBRIDOMA, 18(1), 1999, pp. 13-21
Authors:
Rose, LM
Deng, CT
Scott, SL
Xiong, CY
Lamborn, KR
Gumerlock, PH
DeNardo, GL
Meares, CF
Citation: Lm. Rose et al., Critical Lym-1 binding residues on polymorphic HLA-DR molecules, MOL IMMUNOL, 36(11-12), 1999, pp. 789-797
Authors:
DeNardo, GL
DeNardo, SJ
Shen, S
DeNardo, DA
Mirick, GR
Macey, DJ
Lamborn, KR
Citation: Gl. Denardo et al., Factors affecting I-131-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia, J NUCL MED, 40(8), 1999, pp. 1317-1326
Authors:
DeNardo, SJ
DeNardo, GL
Kukis, DL
Shen, S
Kroger, LA
DeNardo, DA
Goldstein, DS
Mirick, GR
Salako, Q
Mausner, LF
Srivastava, SC
Meares, CE
Citation: Sj. Denardo et al., Cu-67-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma, J NUCL MED, 40(2), 1999, pp. 302-310
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Carr, CE
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma, J NUCL MED, 40(12), 1999, pp. 2014-2020
Authors:
Shen, S
DeNardo, GL
Sgouros, G
O'Donnell, RT
DeNardo, SJ
Citation: S. Shen et al., Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body, J NUCL MED, 40(12), 1999, pp. 2102-2106
Authors:
DeNardo, GL
Citation: Gl. Denardo, Bone pain palliation, CANC BIO R, 13(6), 1998, pp. 407-411
Authors:
DeNardo, GL
Citation: Gl. Denardo, Untitled, CANC BIO R, 13(5), 1998, pp. 335-336
Authors:
O'Donnell, RT
DeNardo, SJ
Miers, LA
Kukis, DL
Mirick, GR
Kroger, LA
DeNardo, GL
Citation: Rt. O'Donnell et al., Combined modality radioimmunotherapy with taxol and Y-90-LYM-1 for Raji lymphoma xenografts, CANC BIO R, 13(5), 1998, pp. 351-361
Authors:
Denardo, SJ
Richman, CM
Kukis, DL
Shen, S
Lamborn, KR
Miers, LA
Kroger, LA
Perez, EA
DeNardo, GL
Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018
Authors:
Kukis, DL
DeNardo, SJ
DeNardo, GL
O'Donnell, RT
Meares, CF
Citation: Dl. Kukis et al., Optimized conditions for chelation of Yttrium-90-DOTA immunoconjugates, J NUCL MED, 39(12), 1998, pp. 2105-2110